“Phosphoproteomics predict response to midostaurin plus chemotherapy in independent cohorts of FLT3-mutated acute myeloid leukaemia”
- eBioMedicine (Lancet) 2024 GO TO SOURCE
“Multi-drug algorithm to accurately predict best first-line treatments in newly-diagnosed acute myeloid leukemia (AML)”
- American Society of Clinical Oncology 2024 GO TO SOURCE
“Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)”
- American Society of Clinical Oncology 2024 GO TO SOURCE
“Phosphoproteomics accurately predicts responses to midostaurin plus chemotherapy in two independent cohorts of FLT3 mutant-positive acute myeloid leukaemia”
- European Hematology Association 2023 GO TO SOURCE
“Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)”
- American Society of Clinical Oncology 2023 GO TO SOURCE
“A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae”
- Science Translational Medicine 2022 GO TO SOURCE
“KScan: personalizing medicine with phosphoproteomics”
- Nature Article 2022 GO TO SOURCE
“Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia”
GO TO SOURCE
“Precision phosphoproteomic analysis in Chr22q11.2 amplified NSCLC cells reveals distinct signaling corruption and response to Aurora kinase B inhibition”
- American Association for Cancer Research 2021 GO TO SOURCE
“Predictive phosphoproteomic signatures for midostaurin plus chemotherapy response in FLT3 mutant positive acute myeloid leukaemia”
- American Society of Clinical Oncology 2021 GO TO SOURCE
“Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets”
- Cancer Research 2021 GO TO SOURCE
“Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways”
- iScience 2021 GO TO SOURCE
“Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring”
- Nature Biotechnology 2020 GO TO SOURCE
“Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells”
- Leukemia 2018 GO TO SOURCE
“Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability”
- Molecular and Cellular Proteomics 2017 GO TO SOURCE
“Empirical inference of circuitry and plasticity in a kinase signaling network”
- Proc Natl Acad Sci USA 2015 GO TO SOURCE
“Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells”
- Science Signaling 2013 GO TO SOURCE